Angiodynamic Inc

NASDAQ:ANGO   3:59:50 PM EDT
28.49
-0.05 (-0.18%)
Other Pre-Announcement

Angiodynamics Sees Fy22 Adjusted EPS In Range Of $0.00 To $0.05

Published: 09/30/2021 11:20 GMT
Angiodynamic Inc (ANGO) - Sees FY2022 Gross Margin to Be About 55.0% .
Now Expects FY2022 Net Sales to Be in Range of $310 Million to $315 Million.
Angiodynamics Reports Fiscal 2022 First Quarter Financial Results; Updates Guidance.
Q1 Adjusted Loss per Share $0.02.
Q1 GAAP Loss per Share $0.18.
Q1 Sales $77 Million Versus Refinitiv Ibes Estimate of $71.3 Million.
Q1 Earnings per Share Estimate $-0.05 -- Refinitiv Ibes Data (analyst estimates).
Sees FY Sales $310 Million to $315 Million.
Sees FY22 Adjusted EPS in Range of $0.00 to $0.05.
Further Company Coverage: .
((reuters.
Briefs@thomsonreuters.
Com;)).